Journal
EXPERT REVIEW OF PROTEOMICS
Volume 19, Issue 7-12, Pages 283-287Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/14789450.2023.2176757
Keywords
AML; drug resistance; FLT3 inhibitor; leukemia; oncoproteomics; phosphoproteomics; proteogenomics